The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis

Kobayashi Hisanori; Ohnishi Takashi; Nakagawa Ryoko; Yoshizawa Kazutake

首页> 外文期刊>International journal of geriatric psychiatry >The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis

【24h】

The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis

机译：胆碱酯酶抑制剂在轻度至中度阿尔茨海默氏病患者中的比较疗效和安全性：贝叶斯网络荟萃分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Comparative evidence for efficacy and safety of second-generation cholinesterase inhibitors (ChEIs) is still sparse.

机译：背景：关于第二代胆碱酯酶抑制剂（ChEIs）功效和安全性的比较证据仍然很少。

著录项

来源
《International journal of geriatric psychiatry 》 |2016年第8期| 共13页
作者
Kobayashi Hisanori; Ohnishi Takashi; Nakagawa Ryoko; Yoshizawa Kazutake;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学 ;
关键词
Alzheimer's disease; cholinesterase inhibitors; meta-analysis;

机译：阿尔茨海默氏病;胆碱酯酶抑制剂;元分析;

相似文献

外文文献
中文文献
专利

1. The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis [J] . Kobayashi Hisanori, Ohnishi Takashi, Nakagawa Ryoko, International journal of geriatric psychiatry . 2016 ,第8期

机译：胆碱酯酶抑制剂在轻度至中度阿尔茨海默氏病患者中的比较疗效和安全性：贝叶斯网络荟萃分析
2. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis [J] . Thancharoen Onnita, Limwattananon Chulaporn, Waleekhachonloet Onanong, Drugs and aging . 2019 ,第5期

机译：Ginkgo Biloba提取物（EGB761），胆碱酯酶抑制剂和用于治疗轻度至中度阿尔茨海默病的致病症：网络元分析
3. Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients [J] . Lídia Blanco-Silvente, Xavier Castells, Marc Saez, The international journal of neuropsychopharmacology . 2017 ,第7期

机译：胆碱酯酶抑制剂对阿尔茨海默氏病的停药，疗效和安全性：纳入16 106名患者的43项随机临床试验的荟萃分析和荟萃回归
4. A Bayesian Review of the Meta-Analysis on the Efficacy of Bone Marrow-Derived Cells Transplantation in Adult Patients with Heart Diseases [C] . Siew-Pang Chan, Rosalind Lee, Kim-Leng Poh World Congress on Engineering . 2009

机译：贝叶斯审查骨髓源细胞移植在成人患者心脏病患者中的疗效综述
5. Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer's Disease in a Long Term Care Setting. [D] . O'Regan, Jordana. 2014

机译：在长期护理环境中评估中度至重度阿尔茨海默氏病患者停用胆碱酯酶抑制剂的安全性。
6. The comparative efficacy and safety of cholinesterase inhibitors in patients with mild‐to‐moderate Alzheimers disease: a Bayesian network meta‐analysis [O] . Hisanori Kobayashi, Takashi Ohnishi, Ryoko Nakagawa, -1

机译：胆碱酯酶抑制剂在轻度至中度阿尔茨海默氏病患者中的比较疗效和安全性：贝叶斯网络荟萃分析
7. Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer’s disease: a network meta-analysis of 41 randomized controlled trials [O] . Kai-Xin Dou, Meng-Shan Tan, Chen-Chen Tan, 2018

机译：胆碱酯酶抑制剂和阿尔茨海默病的比较安全性和有效性：41种随机对照试验的网络荟萃分析

The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis

摘要

著录项

相似文献

相关主题

期刊订阅